Innovax-ND-IBD-ILT

RSS

Authorised

This medicine is authorised for use in the European Union

avian infectious laryngotracheitis / infectious bursal disease / Marek's disease vaccine (live recombinant) / Newcastle disease virus vaccine (inactivated)
MedicineVeterinaryAuthorised

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

Name of medicine
Innovax-ND-IBD-ILT
Active substance
turkey herpesvirus strain HVT/ND/IBD/ILT (cell-associated), expressing the fusion protein gene of Newcastle disease virus, the VP2 protein gene of infectious bursal disease virus and the glycoproteins gD and gI genes of infectious laryngotracheitis virus, live
International non-proprietary name (INN) or common name
  • avian infectious laryngotracheitis
  • infectious bursal disease
  • Marek's disease vaccine (live recombinant)
  • Newcastle disease virus vaccine (inactivated)

Pharmacotherapeutic group

  • Immunologicals for aves
  • Domestic fowl
  • Live viral vaccines

Authorisation details

EMA product number
EMEA/V/C/006442

Assessment history

CVMP summary of positive opinion for Innovax-ND-IBD-ILT

Adopted Reference Number: EMA/155368/2025

English (EN) (125.73 Ko - PDF)

Première publication:
Voir
This page was last updated on

Share this page